AbbVie Hits Roxane With Patent Suit Over Norvir
AbbVie Inc. hit Roxane Laboratories Inc. with an infringement suit in Ohio federal court Thursday, alleging the company's quest to market a generic version of the HIV drug Norvir violates two...To view the full article, register now.
Already a subscriber? Click here to view full article